Clinical trials
Lupus Erythematosus, Systemic trials in Mexico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
101 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 6 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 6 |
| 2018 | 6 |
| 2019 | 5 |
| 2020 | 6 |
| 2021 | 7 |
| 2022 | 11 |
| 2023 | 8 |
| 2024 | 8 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 50 |
| Active, not recruiting | 22 |
| Terminated | 17 |
| Recruiting | 7 |
| Enrolling by invitation | 3 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 7 |
| Novartis Pharmaceuticals | 6 |
| AstraZeneca | 5 |
| Eli Lilly and Company | 5 |
| GlaxoSmithKline | 5 |
| Amgen | 4 |
| Biogen | 4 |
| MedImmune LLC | 4 |
| Viatris Innovation GmbH | 4 |
| AbbVie | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 101 |
| Autoimmune Diseases | 22 |
| Lupus Nephritis | 12 |
| Connective Tissue Diseases | 10 |
| Immune System Diseases | 10 |
| Lupus Erythematosus, Cutaneous | 5 |
| Nephritis | 5 |
| Lupus Erythematosus, Discoid | 4 |
| Bone Diseases, Metabolic | 2 |
| Glomerulonephritis | 2 |
Trials
Showing 51 to 75 of 101. Each trial links to its page on Pharma Observatory.
1 more trial matches. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.